The NordICC-study group is nominated for the category Best Scientific Work by the Felix Burda Award 2017

Centre PI Michael Bretthauer and the NordICC-study group is nominated for the prestigious German research prize The Felix Burda Award 2017 for Best Scientific Work. The prize is awarded in Berlin on the 14 of May at a gala venue broadcasted on German television.

Principal investigator Michael Bretthauer

Link to news article in Norwegian from the The Clinical Effectiveness Research Group homepage: Norske leger nominert til prestisjetung tysk forskningspris

Latest publications

Eilertsen et al. 2020. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. 469: 246-255 Araghi et al. 2020. Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut [Online ahead of print] Lopes et al. 2020. A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis. Gastric Cancer [Online ahead of print] Bruun et al. 2020. Patient-derived organoids from multiple colorectal cancer liver metastases reveal moderate intra-patient pharmacotranscriptomic heterogeneity. Clin. Cancer Res. [Online ahead of print] Brunsell et al. 2020. High concordance and negative prognostic impact of RAS/BRAF/PIK3CA mutations in multiple resected colorectal liver metastases. Clin. Colorectal Cancer [Online ahead of print] All publications